Myostellar is developing novel therapies for treatment of muscular dystrophies. Led by Professor Peter Currie and Associate Professor Mikaël Martino, at the Australian Regenerative Medicine Institute (ARMI). CUREator will support proof of concept studies, critical to the preclinical development of the program.